Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lush

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Ebiomedicine|February 5, 2016
A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal NeoplasiaGregory M Springett, Kazim Husain, Anthony Neuger, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
European Journal of Human Genetics : EJHG|January 1, 1994
The EUROGEM map of human chromosome XM A Aldred, T Flint, R Vossen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancerW D Figg, N Dawson, M N Middleman, et al.
Plant Molecular Biology|September 1, 1989
Recent developments in the molecular genetics and biology of self-incompatibilityA E Clarke, M A Anderson, A Atkinson, et al.
Human Molecular Genetics|March 1, 1993
Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locusP A Crossey, E R Maher, M H Jones, et al.
Journal of Medical Genetics|February 1, 1993
Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor geneF M Richards, E R Maher, F Latif, et al.
Investigational New Drugs|July 21, 2010
Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKTChristopher R Garrett, Domenico Coppola, Robert M Wenham, et al.
Molecular Cancer Therapeutics|August 25, 2006
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trialGeorge R Simon, Richard M Lush, Jana Gump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasmsA M Senderowicz, D Headlee, S F Stinson, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Ebiomedicine|February 5, 2016
A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal NeoplasiaGregory M Springett, Kazim Husain, Anthony Neuger, et al.
The Cancer Journal From Scientific American|May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesotheliomaG Y Ma, D L Bartlett, E Reed, et al.
European Journal of Human Genetics : EJHG|January 1, 1994
The EUROGEM map of human chromosome XM A Aldred, T Flint, R Vossen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancerW D Figg, N Dawson, M N Middleman, et al.
Plant Molecular Biology|September 1, 1989
Recent developments in the molecular genetics and biology of self-incompatibilityA E Clarke, M A Anderson, A Atkinson, et al.
Human Molecular Genetics|March 1, 1993
Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locusP A Crossey, E R Maher, M H Jones, et al.
Journal of Medical Genetics|February 1, 1993
Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor geneF M Richards, E R Maher, F Latif, et al.
Investigational New Drugs|July 21, 2010
Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKTChristopher R Garrett, Domenico Coppola, Robert M Wenham, et al.
Molecular Cancer Therapeutics|August 25, 2006
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trialGeorge R Simon, Richard M Lush, Jana Gump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasmsA M Senderowicz, D Headlee, S F Stinson, et al.
Pageof 7